Tech Centric Healthcare Services Company Continues To Move Forward With Its Business Combination and Exchange Listing
Clearday (CLRD:OTC EXMKT), a tech-centric healthcare services company, has provided an update on its business combination with Viveon Healthcare Acquisition (VHAQ:OTC EXMKT). The company has developed software and digital assistants for the Senior Living sector, delivering therapies and engagement via tablets, smartTVs, and companion robotics. Both companies are working towards completing the combination, which includes listing the combined company's stock on NASDAQ or NYSE American.
Clearday's CEO, James Walesa, acknowledged the challenging financing environment but reaffirmed the company's commitment to the deal. He emphasized that Clearday stockholders will receive shares in the combined company on a pro-rata basis, independent of Clearday's current stock value. The company is also taking steps to complete SEC filings to allow trading on the Pink OTC Market.
Clearday (CLRD:OTC EXMKT), un'azienda di servizi sanitari orientata alla tecnologia, ha fornito un aggiornamento sulla sua fusione con Viveon Healthcare Acquisition (VHAQ:OTC EXMKT). L'azienda ha sviluppato software e assistenti digitali per il settore della senior living, offrendo terapie e coinvolgimento tramite tablet, smartTV e robotica di compagnia. Entrambe le aziende stanno lavorando per completare la fusione, che include l'inclusione delle azioni della società combinata su NASDAQ o NYSE American.
Il CEO di Clearday, James Walesa, ha riconosciuto l'ambiente difficile per il finanziamento, ma ha ribadito l'impegno dell'azienda verso l'accordo. Ha enfatizzato che gli azionisti di Clearday riceveranno azioni nella società combinata su base pro-rata, indipendentemente dal valore attuale delle azioni di Clearday. L'azienda sta anche adottando misure per completare i filing alla SEC per consentire il trading sul Pink OTC Market.
Clearday (CLRD:OTC EXMKT), una empresa de servicios de salud centrada en la tecnología, ha proporcionado una actualización sobre su fusión con Viveon Healthcare Acquisition (VHAQ:OTC EXMKT). La empresa ha desarrollado software y asistentes digitales para el sector de la vivienda para personas mayores, ofreciendo terapias y participación a través de tabletas, smartTV y robótica de compañía. Ambas empresas están trabajando para completar la fusión, que incluye la inclusión de las acciones de la empresa combinada en NASDAQ o NYSE American.
El CEO de Clearday, James Walesa, reconoció el desafiante entorno financiero pero reafirmó el compromiso de la empresa con el acuerdo. Enfatizó que los accionistas de Clearday recibirán acciones de la empresa combinada de manera prorrateada, independientemente del valor actual de las acciones de Clearday. La empresa también está tomando medidas para completar los trámites ante la SEC que permitan el comercio en el Pink OTC Market.
Clearday (CLRD:OTC EXMKT), 기술 중심의 의료 서비스 회사, Viveon Healthcare Acquisition (VHAQ:OTC EXMKT)와의 사업 결합에 대한 업데이트를 제공했습니다. 이 회사는 노인 생활 분야를 위한 소프트웨어 및 디지털 어시스턴트를 개발하여 태블릿, 스마트 TV 및 동반 로봇을 통해 치료 및 참여를 제공합니다. 두 회사는 결합된 회사의 주식을 NASDAQ 또는 NYSE American에 상장하는 것을 포함하는 합병을 완료하기 위해 노력하고 있습니다.
Clearday의 CEO인 James Walesa는 어려운 금융 환경을 인정했지만, 계약에 대한 회사의 의지를 재확인했습니다. 그는 Clearday 주주들이 Clearday의 현재 주식 가치와 관계없이 비례 배분으로 결합된 회사의 주식을 받을 것이라고 강조했습니다. 회사는 또한 Pink OTC 시장에서 거래를 허용하기 위해 SEC 제출을 완료하는 조치를 취하고 있습니다.
Clearday (CLRD:OTC EXMKT), une entreprise de services de santé axée sur la technologie, a fourni une mise à jour sur sa fusion avec Viveon Healthcare Acquisition (VHAQ:OTC EXMKT). L'entreprise a développé des logiciels et des assistants numériques pour le secteur de la vie senior, offrant des thérapies et de l'engagement via des tablettes, des smartTV et de la robotique de compagnie. Les deux entreprises travaillent à finaliser la fusion, qui inclut l'inscription des actions de l'entreprise combinée sur NASDAQ ou NYSE American.
Le PDG de Clearday, James Walesa, a reconnu l'environnement financier difficile tout en réaffirmant l'engagement de l'entreprise envers l'accord. Il a souligné que les actionnaires de Clearday recevront des actions de l'entreprise combinée sur une base pro-rata, indépendamment de la valeur actuelle des actions de Clearday. L'entreprise prend également des mesures pour compléter les dépôts auprès de la SEC afin de permettre le trading sur le Pink OTC Market.
Clearday (CLRD:OTC EXMKT), ein technologieorientiertes Gesundheitsdienstleistungsunternehmen, hat ein Update zu seiner Unternehmensfusion mit Viveon Healthcare Acquisition (VHAQ:OTC EXMKT) bereitgestellt. Das Unternehmen hat Software und digitale Assistenten für den Senior Living-Sektor entwickelt und bietet Therapien und Engagement über Tablets, Smart-TVs und Begleitrobotik an. Beide Unternehmen arbeiten daran, die Fusion abzuschließen, die die Listung der Aktien des fusionierten Unternehmens an NASDAQ oder NYSE American umfasst.
Der CEO von Clearday, James Walesa, erkannte das herausfordernde Finanzierungsumfeld an, bekräftigte jedoch das Engagement des Unternehmens für den Deal. Er betonte, dass die Clearday-Aktionäre Aktien des fusionierten Unternehmens auf pro-rata-Basis erhalten, unabhängig vom aktuellen Aktienwert von Clearday. Das Unternehmen ergreift auch Maßnahmen, um SEC-Einreichungen abzuschließen, um den Handel auf dem Pink OTC Market zu ermöglichen.
- Potential listing on major stock exchange (NASDAQ or NYSE American)
- Development of innovative software and digital assistants for Senior Living sector
- Reaffirmed commitment to business combination with Viveon Healthcare
- Progress towards SEC filings completion for Pink OTC Market trading
- Challenging financing environment due to high interest rates and international conflicts
- No guarantee of approval for initial listing application on national securities exchange
- Financial constraints affecting both Clearday and Viveon
San Antonio, Texas, July 22, 2024 (GLOBE NEWSWIRE) -- Clearday (CLRD:OTC EXMKT ) (“Clearday” or the “Company”) is pleased to inform market participants, partners and stakeholders of the Company’s efforts during the first half of 2024 and reconfirm its efforts for the previously announced business combination with Viveon Healthcare Acquisition Corporation (VHAQ:OTC EXMKT) (“Viveon”).
Clerday has spent years evolving to a tech-centric service provider to the Senior Living sector. The Company has developed software and other services and other services to provide therapies, engagement and encouragement to Older Americans. The software can be delivered via tablet, smartTV or companion robotics. The Company calls these digital assistants.
This work was recognized by Viveon. The Viveon leadership team are experienced professionals with extensive medical device expertise. They recognized the value of the efforts by Clearday to unlock some of the challenges faced by the Senior Living industry. The two companies previously announced a business combination and Viveon and Clearday have jointly worked together to complete this combination. The terms of this combination include listing the common stock of the combined company on an exchange such as NASDAQ or NYSE American.
Mr. Walesa noted that, on July 19, Viveon publicly reconfirmed its commitment to the business combination and Mr. Walesa echoed the statement by Viveon in that recent SEC filing that
The Companies have been working diligently on the transaction and intend to complete the business combination in the near future. The parties are focused on completing the business combination and associated financing to support the execution of the business plan and listing on a major stock exchange. There is no guarantee that the initial listing application for the combined company’s securities will be approved by a national securities exchange.”
James Walesa, the CEO of Clearday, made the following comments and observations, “I have heard from many veteran investment bankers that financings in the last two years have been difficult due several reasons including high interest rates and international conflicts, especially for high growth companies that are resource constrained in both personnel and capital. We appreciate the efforts of all our stakeholders to help Clearday fulfill its potential. As a reminder to all Clearday common stockholders, our agreement with Viveon provides for a set number of shares to the Clearday stockholders. The value of the business combination to our stockholders is not determined by the value of Clearday’s common stock at closing. Clearday stockholders will receive a pro rata basis of shares of the combined company at close of the business combination. Additionally, Clearday is taking actions to complete its SEC filings that would allow our common stock to trade on the Pink OTC Market”.
Walesa continued, “with this in mind, the management of both companies have focused on working together to solve the financial constraints that have challenged both companies, complete their SEC filings and successfully complete the business combination including listing the common stock on an exchange”.
About Clearday
Clearday™ is a publicly traded innovative non-acute longevity healthcare services company with a modern, hopeful vision for making high-quality care options more accessible, affordable, and empowering for older Americans and those who love and care for them and is dedicated to enhancing the lives of adults through innovative cognitive care solutions. With a focus on personalized care and groundbreaking technology, Clearday is at the forefront of redefining the standards of senior living. Clearday has a decade-long experience in non-acute care. Clearday at Home – its digital service – brings Clearday to the intersection of telehealth, Software-as-a-Service (SaaS), and subscription-based content. Learn more about Clearday at myclearday.com.
Forward-Looking Statements
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, forward-looking statements can be identified by the use of terms such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “expect,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target,” “trajectory,” “focus,” “work to,” “attempt,” “pursue,” or other comparable terms. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements are based on certain assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate in the circumstances and are not guarantees of future performance. Actual results may differ materially from those indicated by forward-looking statements as a result of various factors, risks and uncertainties. These forward-looking statements should not be relied upon as representing Clearday’s views as of any date subsequent to the date hereof. This release includes information from third sources from published reports providing such information and we have assumed the accuracy of such reports without independent investigation or inquiry. This communication is for informational purposes only and is neither an offer to sell nor a solicitation of an offer to purchase any securities of the Company.
Media Contact:
Eric Dusansky
504-381-4603
eric@inflectionpartnersllc.com
FAQ
What is the status of Clearday's (CLRD) business combination with Viveon Healthcare?
What technology has Clearday (CLRD) developed for the Senior Living sector?
What are Clearday's (CLRD) plans for stock exchange listing?
How will the business combination affect Clearday (CLRD) stockholders?
